The aim of this study was to investigate the effects of glutamine on the histomorphology of the liver, oxidative stress and nuclear factor-κB (NF-κB) expression in the development of nonalcoholic fatty liver disease (NAFLD). Here, NFKB1 is linked to metabolic dysfunction-associated steatotic liver disease.